About Vivasure Medical
Vivasure Medical is a company based in Galway (Ireland) founded in 2009 by Chris Martin and Gerard Brett was acquired by Haemonetics in January 2026.. Vivasure Medical has raised $92.08 million across 10 funding rounds from investors including Orchestra BioMed, Haemonetics and European Investment Bank. Vivasure Medical offers products and services including PerQseal and PerQseal+. Vivasure Medical operates in a competitive market with competitors including TISSIUM, Aziyo Biologics, Cardival Medical, Laminate Medical and EKOS Corporation, among others.
- Headquarter Galway, Ireland
- Founders Chris Martin, Gerard Brett
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vivasure Medical Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$92.08 M (USD)
in 10 rounds
-
Latest Funding Round
$31.93 M (USD), Series D
Mar 13, 2023
-
Investors
Orchestra BioMed
& 11 more
-
Employee Count
Employee Count
-
Acquired by
Haemonetics
(Jan 09, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vivasure Medical
Vivasure Medical offers a comprehensive portfolio of products and services, including PerQseal and PerQseal+. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides percutaneous closure for large arteriotomies in cardiovascular procedures.
Offers next-generation solution for secure vessel closure in clinical settings.
Funding Insights of Vivasure Medical
Vivasure Medical has successfully raised a total of $92.08M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $31.93 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $31.9M
-
First Round
First Round
(04 Feb 2009)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Grant - Vivasure Medical | Valuation |
investors |
|
| Mar, 2023 | Amount | Series D - Vivasure Medical | Valuation | Haemonetics |
|
| May, 2022 | Amount | Series D - Vivasure Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vivasure Medical
Vivasure Medical has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Orchestra BioMed, Haemonetics and European Investment Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Risk capital is provided to life sciences entrepreneurs.
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vivasure Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vivasure Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vivasure Medical Comparisons
Competitors of Vivasure Medical
Vivasure Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Aziyo Biologics, Cardival Medical, Laminate Medical and EKOS Corporation, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| domain | founded_year | HQ Location |
A device for vascular access management is developed.
|
|
| domain | founded_year | HQ Location |
AV fistula maturation and patency are supported by VasQ device.
|
|
| domain | founded_year | HQ Location |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vivasure Medical
Frequently Asked Questions about Vivasure Medical
When was Vivasure Medical founded?
Vivasure Medical was founded in 2009.
Where is Vivasure Medical located?
Vivasure Medical is headquartered in Galway, Ireland.
Who is the current CEO of Vivasure Medical?
Andrew Glass is the current CEO of Vivasure Medical.
Is Vivasure Medical a funded company?
Vivasure Medical is a funded company, having raised a total of $92.08M across 10 funding rounds to date. The company's 1st funding round was a Series D of $22.92M, raised on Feb 04, 2009.
What does Vivasure Medical do?
Vivasure Medical was founded in 2009 in Galway, Ireland, within the medical devices sector. Patented bioabsorbable implant technology and percutaneous delivery systems have been created for closing large arteriotomies during transcatheter procedures. The PerQseal system features a patch-based implant that is fully absorbable and CE marked, supporting vascular access site management in interventional cardiology operations.
Who are the top competitors of Vivasure Medical?
Vivasure Medical's top competitors include TISSIUM, Cardival Medical and Aziyo Biologics.
What products or services does Vivasure Medical offer?
Vivasure Medical offers PerQseal and PerQseal+.
Who are Vivasure Medical's investors?
Vivasure Medical has 12 investors. Key investors include Orchestra BioMed, Haemonetics, European Investment Bank, Enterprise Ireland, and European Union.